Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangjia Ruangan Granules for Chronic Hepatitis B Liver Fibrosis (Phase II)
CTR20181151Phase 2Completed
- Sponsor
- Mudanjiang Youbo Pharmaceutical
- Start
- Jul 2018
- Countries
- 1
01
Overview
A Phase 2 trial of Huangjia Ruangan Granules in Chronic Hepatitis B (CHB), hepatic fibrosis, sponsored by Mudanjiang Youbo Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
Huangjia Ruangan Granules
03
Conditions
Chronic Hepatitis B (CHB)hepatic fibrosis
Beyond the preview
Go deeper on CTR20181151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181151.